Vafidemstat: a lysine-specific demethylase 1A inhibitor that shows promise for treating neuropsychiatric disorders
The enzyme KDM1A encoded by KDM1A and also known as lysine-specific demethylase 1 (LSD1) plays important roles in the development and function of the brain. Vafidemstat is a KDM1A inhibitor that has shown beneficial effects in preclinical and clinical trials for the treatment of neuropsychiatric dis...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2025-12-01
|
| coleção: | Epigenetics Reports |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/28361512.2025.2552947 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|